9 months ago
GILD
AnalystsAsthika GoonewardeneAsthika Goonewardene's Stock Forecasts
AnalystsAsthika Goonewardene
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4562 out of 5267 analysts
Average Return
-0.48%
Win Rate
43%44 out of 102
Risk vs Reward
Poor
Good
Asthika Goonewardene's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +265.19% | $40.50 | $147.90 | 2025-09-04 - 2026-05-04 | Strong Buy |
Mersana Therapeutics IncMRSN | +222.63% | $8.50 | $27.43 | 2025-05-15 - 2025-11-13 | Strong Buy |
Immunogen IncIMGN | +180.83% | $5.32 | $14.94 | 2022-11-20 - 2023-11-20 | Strong Buy |
Forty Seven IncFTSV | +163.68% | $35.74 | $94.24 | 2020-01-12 - 2020-03-03 | Strong Buy |
Allogene Therapeutics IncALLO | +137.15% | $0.95 | $2.26 | 2025-05-13 - 2026-05-04 | Strong Buy |
Asthika Goonewardene Analyst Color
Get additional color on Asthika Goonewardene's coverage of popular stocks
2 years ago
IOVA
2 years ago
ACLX
Asthika Goonewardene's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcellx IncACLX | 6 | Hold | $120.00 | +4.28% | Downgrades | 2 months ago |
Zymeworks IncZYME | 1 | Strong Buy | $40.00 | +49.37% | Initiates Coverage On | 5 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $43.00 | +41.54% | Initiates Coverage On | 5 months ago |
Mersana Therapeutics IncMRSN | 4 | Hold | $30.75 | +5.74% | Downgrades | 6 months ago |
Genmab AGMAB | 14 | Strong Buy | $48.00 | +77.51% | Reiterates | 6 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $145.00 | +9.28% | Reiterates | 6 months ago |
Arcus Biosciences IncRCUS | 2 | Strong Buy | $39.00 | +49.71% | Reiterates | 7 months ago |
Merus NvMRUS | 3 | Hold | $97.00 | +7.78% | Downgrades | 7 months ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $100.00 | +593.48% | Initiates Coverage On | 8 months ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $99.00 | -33.06% | Initiates Coverage On | 8 months ago |
Exelixis IncEXEL | 10 | Strong Buy | $49.00 | +10.94% | Maintains | 9 months ago |
Igm Biosciences IncIGMS | 9 | Hold | $1.00 | -21.26% | Maintains | a year ago |
Biontech SeBNTX | 3 | Strong Buy | $155.00 | +56.01% | Reiterates | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $71.00 | +167.92% | Maintains | a year ago |
Allogene Therapeutics IncALLO | 6 | Strong Buy | $10.00 | +342.48% | Maintains | a year ago |
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $7.00 | N/A | Downgrades | a year ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Sutro Biopharma IncSTRO | 6 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Compugen LtdCGEN | 5 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Caribou Biosciences IncCRBU | 3 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 3 | Hold | $229.00 | N/A | Reiterates | 3 years ago |
Hookipa Pharma IncHOOK | 4 | Strong Buy | $40.00 | N/A | Reiterates | 3 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $432.00 | N/A | Reiterates | 3 years ago |
Immunogen IncIMGN | 2 | Strong Buy | $18.00 | N/A | Maintains | 3 years ago |
Instil Bio IncTIL | 1 | Hold | $120.00 | N/A | Reinstates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Harpoon Therapeutics IncHARP | 3 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Celularity IncCELU | 2 | Hold | $60.00 | N/A | Maintains | 4 years ago |
Nextcure IncNXTC | 4 | Strong Buy | $180.00 | N/A | Maintains | 4 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.